Ion channels in T lymphocytes: An update on facts, mechanisms and therapeutic targeting in autoimmune diseases
Authors:
- 1 May 2010
- journal article
- review article
- Published by Elsevier in Immunology Letters
- Vol. 130 (1-2) , 19-25
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Blockade of T-Lymphocyte KCa3.1 and Kv1.3 Channels as Novel Immunosuppression Strategy to Prevent Kidney Allograft RejectionTransplantation Proceedings, 2009
- The CRAC channel consists of a tetramer formed by Stim-induced dimerization of Orai dimersNature, 2008
- Orai1 and STIM1 move to the immunological synapse and are up-regulated during T cell activationProceedings of the National Academy of Sciences, 2008
- Targeting Effector Memory T Cells with the Small Molecule Kv1.3 Blocker PAP-1 Suppresses Allergic Contact DermatitisJournal of Investigative Dermatology, 2007
- Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseasesProceedings of the National Academy of Sciences, 2006
- A mutation in Orai1 causes immune deficiency by abrogating CRAC channel functionNature, 2006
- STIM1 is a Ca2+ sensor that activates CRAC channels and migrates from the Ca2+ store to the plasma membraneNature, 2005
- STIM Is a Ca2+ Sensor Essential for Ca2+-Store-Depletion-Triggered Ca2+ InfluxCurrent Biology, 2005
- Topology of the pore-region of a K+ channel revealed by the NMR-derived structures of scorpion toxinsNeuron, 1995
- The charybdotoxin receptor of a Shaker K+ channel: Peptide and channel residues mediating molecular recognitionNeuron, 1994